David Charles Lubner - 06 Jul 2021 Form 4 Insider Report for POINT Biopharma Global Inc.

Role
Director
Signature
/s/ William L. Demers, by Power of Attorney for David Charles Lubner
Issuer symbol
N/A
Transactions as of
06 Jul 2021
Net transactions value
$0
Form type
4
Filing time
08 Jul 2021, 16:38:55 UTC
Previous filing
27 May 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 06 Jul 2021 Common Stock 25,000 $8.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on July 6, 2022 with the remaining 75% vesting in three equal annual installments thereafter.

Remarks:

Power of Attorney is attached to this Form 4 as Exhibit 24